Imagenetix IAGX · USD

Market value

$2,834

Last close × shares

Volume

1k

Shares, 30 Oct 2026

Its shares trade under the ticker IAGX. It has been listed since 1 December 1993. In the fiscal year to 31 March 2015, it reported revenue of $824,499 and a net loss of $21,712. At that date it held total assets of $8.8m and shareholders' equity of $6.3m.

Imagenetix, Inc. develops, formulates and markets over-the-counter and natural-based nutritional supplements and skin care products. The company is headquartered in San Diego, California. The firm's products are offered through multiple channels of distribution, including direct marketing companies, also known as network marketing or multi-level marketing companies and chain store retailers. Its primary product is Celadrin, a product formulation, which it sells to the mass market through retailers and on a private label basis to wholesale customers. The firm licenses its intellectual property to third parties. The company is focused on two medical need areas, which include human and animal conditions related to inflammation and obesity. The company has researched and developed active compositions in the areas of joint health, arthritis and periodontal disease, among others. The firm sells its own branded product, Celadrin, directly to the mass markets through retail sellers. The company also offers Celadrin products through wholesale customers.

Figures and description from our data supplier, not checked against the company's own report.

More about Imagenetix →

We have not reported on Imagenetix yet.

Leaves out fees, taxes and financing.

Chart

TradingView

Close and company data

Our data supplier

News

Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.